Get started
Author

Manuela Pardeo

Observed names: M Pardeo, M. Pardeo, MANUELA PARDEO, Pardeo, M, Pardeo, Manuela
Observed institutions: Università Cattolica del Sacro Cuore, Amgen (United States), University of Cartagena, Universidade de São Paulo, Agostino Gemelli University Polyclinic, Hospital Infantil Universitario Niño Jesús, Bambino Gesù Children's Hospital, Asklepios Klinik Sankt Augustin, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Istituti di Ricovero e Cura a Carattere Scientifico, University Hospital Cologne, Paediatric Rheumatology INternational Trials Organization (PRINTO), University of Brescia
ORCID: 0000-0003-0850-7351
Observed ORCID: 0000-0003-0850-7351
OpenAlex ID: A5055904789
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
2019 · Jurgen Sota, Antonella Insalaco, et al. · Frontiers in Pharmacology · 616
PDF
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series
2010 · Peter A. Nigrovic, Melissa Mannion, et al. · Arthritis & Rheumatism · 463
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study
2017 · Roberta Caorsi, Federica Penco, et al. · Annals of the Rheumatic Diseases · 261
PDF
Efficacy and safety of emapalumab in macrophage activation syndrome
2023 · Fabrizio De Benedetti, Alexei A Grom, et al. · Annals of the Rheumatic Diseases · 156
PDF
Dealing with Chronic Non-Bacterial Osteomyelitis: a practical approach
2017 · Andrea Taddio, Giovanna Ferrara, et al. · Pediatric Rheumatology · 88
PDF
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
2016 · Antonio Vitale, Antonella Insalaco, et al. · Frontiers in Pharmacology · 88
PDF
Is serum troponin T a useful marker of myocardial damage in newborn infants with perinatal asphyxia?
2007 · S. Costa, E Zecca, et al. · Acta Paediatrica · 88
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
2018 · for the “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology), Jurgen Sota, et al. · Clinical Rheumatology · 82
Catch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial
2014 · Fabrizio De Benedetti, Hermine Brunner, et al. · Arthritis & Rheumatology · 81
Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH
2022 · Arianna De Matteis, Manuela Colucci, et al. · Blood · 72
Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis
2020 · Jessica Tibaldi, Angela Pistorio, et al. · Lara D. Veeken · 68
PDF
Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies
2017 · Manuela Pardeo, Claudia Bracaglia, et al. · Best Practice & Research Clinical Rheumatology · 67
Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
2008 · G De Rosa, M Pardeo, et al. · PubMed · 61
Early Treatment and IL1RN Single‐Nucleotide Polymorphisms Affect Response to Anakinra in Systemic Juvenile Idiopathic Arthritis
2020 · Manuela Pardeo, Marianna Nicoletta Rossi, et al. · Arthritis & Rheumatology · 59
Variable Clinical Phenotypes and Relation of Interferon Signature with Disease Activity in ADA2 Deficiency
2019 · Antonella Insalaco, Gian Marco Moneta, et al. · The Journal of Rheumatology · 53
PDF
Chronic nonbacterial osteomyelitis — clinical and magnetic resonance imaging features
2020 · Paola d’Angelo, Laura Tanturri de Horatio, et al. · Pediatric Radiology · 50
PDF
Anakinra in Systemic Juvenile Idiopathic Arthritis: A Single-center Experience
2015 · Manuela Pardeo, Denise Pires Marafon, et al. · The Journal of Rheumatology · 49
PDF
Anakinra in a Cohort of Children with Chronic Nonbacterial Osteomyelitis
2017 · Manuela Pardeo, Denise Pires Marafon, et al. · The Journal of Rheumatology · 48
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project
2024 · Francesco Baldo, Remco G A Erkens, et al. · Lara D. Veeken · 44
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
2019 · Jurgen Sota, Donato Rigante, et al. · Frontiers in Pharmacology · 41
PDF
The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis
2019 · Giusi Prencipe, Claudia Bracaglia, et al. · PLoS ONE · 37
PDF
Safety and Efficacy of Etanercept in a Cohort of Patients with Juvenile Idiopathic Arthritis Under 4 Years of Age
2012 · CLAUDIA BRACAGLIA, PAOLA S. BUONUOMO, et al. · The Journal of Rheumatology · 37
PDF
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
2021 · Nicolino Ruperto, Hermine I Brunner, et al. · Lara D. Veeken · 33
PDF
Infliximab therapy in pediatric Takayasu’s arteritis: report of two cases
2009 · Paola Sabrina Buonuomo, Claudia Bracaglia, et al. · Rheumatology International · 31
Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis
2021 · Martina Capponi, Denise Pires Marafon, et al. · Pediatric Rheumatology · 29
PDF
Works count: 138
Citation count: 3,420
H-index: 27
I10-index: 57
Year
Topic
Type